부산대학교 도서관

Bohula, Erin A, MD; Scirica, Benjamin M, MD; Inzucchi, Silvio E, Prof; McGuire, Darren K, Prof; Keech, Anthony C, Prof; Smith, Steven R, MD; Kanevsky, Estella, MS; Murphy, Sabina A, MPH; Leiter, Lawrence A, Prof; Dwyer, Jamie P, Prof; Corbalan, Ramon, MD; Hamm, Christian, Prof; Kaplan, Lee, MD; Nicolau, Jose Carlos, Prof; Ophuis, Ton Oude, MD; Ray, Kausik K, Prof; Ruda, Mikhail, Prof; Spinar, Jindrich, MD; Patel, Tushar, PhD; Miao, Wenfeng, MD; Perdomo, Carlos, MS; Francis, Bruce, MD; Dhadda, Shobha, PhD; Bonaca, Marc P, MD; Ruff, Christian T, MD; Sabatine, Marc S, Prof; Wiviott, Stephen D, MD; Inzucchi, Silvio; Keech, Anthony; Satlin, Andrew; Brown, Conville; Budaj, Andrzej; Dwyer, Jamie; Garcia-Castillo, Armando; Gupta, Milan; Oude Ophuis, Ton; Ray, Kauski; Weissman, Neil; White, Harvey D; Amerena, J; Arstall, M; Colquhoun, D; Jayasinghe, R; Lee, A; Lehman, R; Moses, R; Proietto, J; Purnell, P; Waites, J; Blombery, P; Cross, D; Worthley, M; d'Emden, M; Selvanayagam, J; Oqueli, RE; Whelan, A; Garrahy, P; de Looze, F; Ninio, D; Horowitz, J; William, M; Suranyi, M; Wittert, G; Le May, M; Pandey, AS; Vizel, S; Labonte, R; Beaudry, Y; Fortin, C; Bell, A; Kouz, S; St-Amour, É; Bata, I; St Maurice, F; Chehayeb, R; Constance, C; Wong, G; Hess, A; Liutkus, J; Poirier, P; Teitelbaum, I; Berlingieri, J; Cha, J; Hartleib, M; Heffernan, M; Twum-Barima, D; Pandith, V; Aronson, R; Goldenberg, R; Ajala, B; Jain, A; Ross, S; Bajaj, H; Khandwala, H; Yared, Z; Gupta, N; Bédard, J; Wharton, S; Blouin, F; Savard, D; Shukla, D; Cobos, J; Godoy, G; Perez, L; Pincetti, C; Saavedra Guajardo, V; Varleta, P; Conejeros, C; Lanas, F; Bayram Llamas, E; Cardona Muñoz, E; Garcia, R; Garza Ruiz, J; Llamas Esperon, G; Lopez Rosas, E; Melendez Mier, G; Ramos, G; Hart, H; Scott, D; Ternouth, I; Benatar, J; Elliott, J; Cutfield, R; Manning, P; Williams, M; Ferrier, K; Scott, R; Wilson, S; Leikis, R; Nirmalaraj, BK; Krzyżagórska, E; Miękus, P; Bronisz, M; Mirek-Bryniarska, E; Łanda, K; Stasiewski, A; Żechowicz, T; Zytkiewicz-Jaruga, D; Korecki, J; Ogórek, M; Pawłowicz, L; Piepiorka, M; Skierkowska, J; Stankiewicz, A; Szyprowska, E; Witek, R; Bochenek, A; Kończakowski, P; Wojnowski, Ł; Wujkowski, M; Cymerman, K; Korzeniak, R; Mąder, P; Mikłaszewicz, B; Stachlewski, P; Goch, A; Pomiećko, W; Skórski, M; Romanowski, L; Jusiak, K; Laskowska-Derlaga, E; Bijata-Bronisz, R; Kaźmierczak, J; Goldberg, R; Henderson, D; Korban, E; Rohr, K; Claxton, E; Weiss, R; Angiolillo, D; Boccalandro, F; Chu, K; Thorn, E; Randhawa, P; Singh, N; Bittar, G; Guarnieri, T; Saeed, S; Sharma, S; Shepard, M; French, W; Desai, P; Bernstein, R; Rogers, W; Singal, R; Schneider, R; Shanes, J; Ong, S; Condit, J; Donahoe, S; Brill, D; Einhorn, D; Ebrahimi, R; Labroo, A; Graf, R; Scott, J; Hoekstra, J; Jetty, P; Luckasen, G; O'Donnell, P; Gonte, W; Pomposini, D; Quadrel, M; Koren, M; Schlager, D; Schramm, E; Singal, D; Lupovitch, S; Soni, A; Seigel, P; Roberts, J; Soufer, J; Reza, S; Quinlan, E; Moretto, T; First, B; Khan, M; Chilka, S; Colfer, H; Teklinski, A; Wallace-Wilding, K; Ellison, H; Muse, D; Aronoff, S; Higgins, A; Patel, S; Elinoff, V; Karim, A; Awasty, V; Chuang, R; Roseman, H; Dugano-Daphnis, P; Albert, M; Sheikh, K; Bays, H; Kaster, S; Goldstein, M; Rubino, D; Calatayud, G; Snyder, H; Williams, T; Hershon, K; Hagan, M; Isserman, S; Kahn, B; Anderson, J; Gimness, MP; Raisinghani, A; Christina, M; Raikhel, M; Gillespie, E; Portnay, E; Heiman, M; Qureshi, M; Lee, J; Blonder, R; Cucher, F; Miller, G; Kotlaba, D; Cornett, G; Beavins, J; Augenbraun, C; Reinhardt, S; Bartkowiak, A, Jr; Salacata, A; Blevins, T; Benjamin, S; Diener, J; George, W; Barker, B; Richwine, R; Baldari, D; Alfieri, A; Barreto, A; Zhang, L; Shah, R; Hendrix, E; Subramaniyam, V; Hurley, S; Lillestol, M; O'Donoghue, M; Shayani, S; Ryan, E; Call, R; Zemel, L; Chang, A; Kivitz, A; Freyne, B; Bland, V; Shore, K; Mostel, E; Uzoaga, E; Andrawis, N; Gabra, N; Ghitis, A; Sabatino, K; Browder, D; Varma, S; Smith, S; Fink, R; Aycock, GR, Jr; Doty, WD; Alfonso, T; Eshaghian, S; Karlsberg, R; Zarich, S; Landau, C; McKenzie, M; Krause, R; Davis, W; Haddad, T; Voyce, S; Alford, C; LeDoux, J; O'Dea, D; Park, J; Aroda, V; Getaneh, A; Graham, B; Bhagwat, R; Korn, D; Ruoff, G; Wiseman, A; Lieber, I; Fialkow, J; Gonzalez-Campoy, JM; Bayron, C; Bertolet, B; Lash, J; Gerrish, C; Robertson, D; Rosenfeld, J; Seidner, M; Agaiby, J; Silverfield, J; Sugimoto, D; Lubin, B; Alhaddad, M; Lui, H; Lakin, G; Chokshi, S; Donovan, D; Felten, W; Minton, S; Kimmelstiel, C; Kuvin, J; Still, C; Byars, W; Talano, J; Desai, V; Bradley, AJ, III; Baker, S; Chane, M; Mercado, A; Baron, S; Harris, B; Mayer, N; Concha, M; Carr, K; Chaykin, L; Willis, J; Clay, A; Fenstad, E; Furda, J; Peterson, P; Chang, M; Aronne, L; Jones, D; Prashad, R; Benson, M; Stegemoller, R; Longshaw, K; Saleh, J; Jennings, W; Detweiler, R; Viswanath, D; Patel, R; Lederman, S; Weinstein, D; Korabathina, R; Singh, V; Rosen, J; Estevez, R; Levin, P; McNeill, R; Kalen, V; Reed, J; Ashley, R; Herman, L; Tsai, Y; Kayne, D; White, A; Hussain, I; Tami, L; Cohen, K; Robinson, J; Fuchs-Ertman, D; Platt, G; Belardo, L; Reddy, R; Rosendorff, C; Saba, F; Powell, S; Anderson, K; Abidi, M; Rezkalla, S; Paraschos, A; Wilson, J; Moursi, M; Shah, A; Nadar, V; Stonesifer, L; Bialow, M; Cannon, K; Ellison, W; Stedman, M; Brown, J; Harper, W; Lucas, KJ; DiGiovanna, M; Rodbard, H; Biscoveanu, M; Davis, C; Hall, J; Littlefield, R; Gorman, T; Kereiakes, D; Chang, FM; Tatu, H; Cheung, D; Kaine, J; Knutson, T; Logemann, T; Pueblitz, G; Bianco, J; Henson, B; Neustel, M; Gelernt, M; Nelson, W; Moriarty, K; Lefebvre, G; Maw, K; Rink, L; Behn, P; Studdard, H; Argoud, G; O'Connor, T; Krichmar, P; Raad, G; Pereles-Ortiz, J; Sorli, C; Cohen, A; Pettis, K; Cavanaugh, B; Phillips, C; Wahlen, J; Radin, D; Rider, J; Kosinski, E; Leimbach, W; Odhav, A; Hakas, J; Tan, A; Howell, M; Wombolt, D; Fishman, N; Shah, P; Wylie, P; Arauz-Pacheco, C; Cavale, A; George, A; Kroll, R; Krantzler, J; Tahirkheli, N; Jabro, M; Newell, M; Mullen, P; Gencheff, N; Meli, J; Vora, K; Kotek, L; Pyzdrowski, K; Paez, H; Moran, J; Tannenbaum, A; Deck, K; Busch, R; Levinson, L; Azizad, M; Whitaker, J; Fox, B; Huffman, C; Ashraf, M; Diogo, J; Kushner, R; Tallet, J; Channamsetty, V; Suh, D; Atieh, M; Navas, J; Young, V; Shaw, S; Dor, I; Duffy, B; Rubin, P; Lewis, D; Kaye, W; Benton, R; Burbano, J; Hotchkiss, D; Magno, A; Alberton, A; Collins, J; Alvarado, O; Stich, M; Mahal, S; Liu, J; Hong, M; Dy, J; Block, B; Lamantia, J; Pritchard, J; Davis, M; Srivastava, S; Bilazarian, S; Rosario, R; McCartney, M; Blumberg, V; Rajan, R; Martin, E; Wright, S; Brinson, C; Johnston, J; Graves, M; Dominguez, M; McKenzie, W; Abadier, R; Tran, C; Castello, R; Morawski, E; White, J; Morris, F; Perez, A; Trueba, P; Sanchez, M; Andersen, J; Kastelic, R; Khan, J; Rodriguez, H; Izquierdo, W; Matias, A; Essandoh, L; Ince, C

The Lancet. 392(10161):2269-2279

Steg, PG; Szarek, M; Bhatt, DL; Bittner, VA; Bregeault, M-F; Dalby, AJ; Diaz, R; Edelberg, JM; Goodman, SG; Hanotin, C; Harrington, RA; Jukema, JW; Lecorps, G; Mahaffey, KW; Moryusef, A; Ostadal, P; Parkhomenko, A; Pordy, R; Roe, MT; Tricoci, P; Vogel, R; White, HD; Zeiher, AM; Schwartz, GG; Sasiela, WJ; Tamby, J-F; Aylward, PE; Drexel, H; Sinnaeve, P; Dilic, M; Gotcheva, NN; Prieto, J-C; Yong, H; Lopez-Jaramillo, P; Pecin, I; Reiner, Z; Poulsen, SH; Viigimaa, M; Nieminen, MS; Danchin, N; Chumburidze, V; Marx, N; Liberopoulos, E; Valdovinos, PCM; Tse, H-F; Kiss, RG; Xavier, D; Zahger, D; Valgimigli, M; Kimura, T; Kim, HS; Kim, S-H; Kedev, S; Erglis, A; Laucevicius, A; Yusoff, K; Lopez, R; Ramos Lopez, GA; Alings, M; Halvorsen, S; Correa Flores, RM; Sy, RG; Budaj, A; Morais, J; Dorobantu, M; Karpov, Y; Ristic, AD; Chua, T; Murin, J; Fras, Z; Tunon, J; De Silva, HA; Hagstrom, E; Muller, C; Chiang, C-E; Sritara, P; Guneri, S; Ray, KK; Moriarty, PM; Chaitman, B; Kelsey, SF; Olsson, AG; Rouleau, J-L; Simoons, ML; Alexander, K; Meloni, C; Rosenson, R; Sijbrands, EJG; Alexander, JH; Armaganijan, L; Bagai, A; Bahit, MC; Brennan, JM; Clifton, S; DeVore, AD; Deloatch, S; Dickey, S; Dombrowski, K; Ducrocq, G; Eapen, Z; Endsley, P; Eppinger, A; Harrison, RW; Hess, CN; Hlatky, MA; Jordan, JD; Knowles, JW; Kolls, BJ; Kong, DF; Leonardi, S; Lillis, L; Maron, DJ; Marcus, J; Mathews, R; Mehta, RH; Mentz, RJ; Moreira, HG; Patel, CB; Pereira, SB; Perkins, L; Povsic, TJ; Puymirat, E; Jones, WS; Shah, BR; Sherwood, MW; Stringfellow, K; Sujjavanich, D; Toma, M; Van Diepen, SFP; Wilson, MD; Yan, AT-K; Lopes, RD; Trotter, C; Schiavi, LB; Garrido, M; Alvarisqueta, AF; Sassone, SA; Bordonava, AP; Alves De Lima, AE; Schmidberg, JM; Duronto, EA; Caruso, OC; Novaretto, LP; Angel Hominal, M; Montana, OR; Caccavo, A; Gomez Vilamajo, OA; Lorenzatti, AJ; Cartasegna, LR; Paterlini, GA; Mackinnon, IJ; Caime, GD; Amuchastegui, M; Salomone, R; Codutti, OR; Jure, HO; Bono, JOE; Hrabar, AD; Vallejos, JA; Ahuad Guerrero, RA; Novoa, F; Patocchi, CA; Zaidman, CJ; Giuliano, ME; Dran, RD; Vico, ML; Carnero, GS; Guzman, PN; Medrano Allende, JC; Garcia Brasca, DF; Bustamante Labarta, MH; Nani, S; Blumberg, EDS; Colombo, HR; Liberman, A; Luciardi, HL; Waisman, GD; Berli, MA; Duran, ROG; Cestari, HG; Luquez, HA; Giordano, JA; Saavedra, SS; Zapata, G; Costamagna, O; Llois, S; Waites, JH; Collins, N; Soward, A; Hii, CLS; Shaw, J; Arstall, MA; Horowitz, J; Rogers, JF; Colquhoun, D; Oqueli Flores, RE; Roberts-Thomson, P; Raffel, O; Lehman, SJ; Aroney, C; Coverdale, SGM; Garrahy, PJ; Starmer, G; Sader, M; Carroll, PA; Dick, R; Zweiker, R; Hoppe, U; Huber, K; Berger, R; Weidinger, F; Faes, D; Hermans, K; Pirenne, B; Leone, A; Hoffer, E; Vrolix, MCM; De Wolf, L; Wollaert, B; Castadot, M; Dujardin, K; Beauloye, C; Vervoort, G; Striekwold, H; Convens, C; Roosen, J; Barbato, E; Claeys, M; Cools, F; Terzic, I; Barakovic, F; Midzic, Z; Pojskic, B; Fazlibegovic, E; Durak-Nalbantic, A; Vulic, D; Muslibegovic, A; Goronja, B; Reis, G; Sousa, L; Nicolau, JC; Giorgeto, FE; Silva, RP; Maia, LN; Rech, R; Rossi, PRF; Cerqueira, MJAG; Duda, N; Kalil, R; Kormann, A; Abrantes, JAM; Pimentel Filho, P; Soggia, AP; De Santos, MON; Neuenschwander, F; Bodanese, LC; Michalaros, YL; Eliaschewitz, FG; Vidotti, MH; Leaes, PE; Botelho, RV; Kaiser, S; Fernandes Manenti, ERF; Precoma, DB; Moura Jorge, JC; Silva, PGMDB; Silveira, JA; Saporito, W; Marin Neto, JA; Feitosa, GS; Ritt, LEF; De Souza, JA; Costa, F; Souza, WKSB; Reis, HJL; Machado, L; Aidar Ayoub, JC; Todorov, GV; Nikolov, FP; Velcheva, ES; Tzekova, ML; Benov, HO; Petranov, SL; Tumbev, HS; Shehova-Yankova, NS; Markov, DT; Raev, DH; Mollov, MN; Kichukov, KN; Ilieva-Pandeva, KA; Ivanova, R; Mincheva, VM; Lazov, PV; Dimov, BI; Senaratne, M; Stone, J; Kornder, J; Pearce, S; Dion, D; Savard, D; Pesant, Y; Pandey, A; Robinson, S; Gosselin, G; Vizel, S; Hoag, G; Bourgeois, R; Morisset, A; Sabbah, E; Sussex, B; Kouz, S; MacDonald, P; Diaz, A; Michaud, N; Fell, D; Leung, R; Vuurmans, T; Lai, C; Nigro, F; Davies, R; Nogareda, G; Vijayaraghavan, R; Ducas, J; Lepage, S; Mehta, S; Cha, J; Dupuis, R; Fong, P; Rodes-Cabau, J; Fadlallah, H; Cleveland, D; Thao, H; Bata, I; Hameed, A; Pincetti, C; Potthoff, S; Prieto, JC; Acevedo, M; Aguirre, A; Vejar, M; Yanez, M; Araneda, G; Fernandez, M; Perez, L; Varleta, P; Florenzano, F; Huidobro, L; Raffo, CA; Olivares, C; Nahuelpan, L; Montecinos, H; Chen, J; Dong, Y; Huang, W; Wang, J; Huang, S; Yao, Z; Li, X; Cui, L; Lin, W; Sun, Y; Li, J; Zhang, X; Zhu, H; Chen, D; Huang, L; Dong, S; Su, G; Xu, B; Su, X; Cheng, X; Lin, J; Zong, W; Li, H; Feng, Y; Xu, D; Yang, X; Ke, Y; Lin, X; Zhang, Z; Zheng, Z; Luo, Z; Chen, Y; Ding, C; Zheng, Y; Peng, D; Li, Y; Wei, M; Liu, S; Yu, Y; Qu, B; Jiang, W; Zhou, Y; Zhao, X; Yuan, Z; Guo, Y; Xu, X; Shi, X; Ge, J; Fu, G; Bai, F; Fang, W; Shou, X; Lu, Q; Zhang, R; Zhu, J; Xu, Y; Fan, Z; Li, T; Wu, C; Jaramillo, N; Vallejo, GS; Botia, DCL; Lopez, RB; De Salazar, DIM; Bonfanti, AJC; Higuera, JD; Silva, SIB; Lozada, HJG; Arroyo, JAC; Mendoza, JLA; Ruiz, RLF; Jatin, FGM; Herazo, AS; Parada, JC; Triana, MAU; Strozzi, M; Car, S; Milicic, D; Bencic, ML; Pintaric, H; Prvulovic, D; Sikic, J; Persic, V; Mileta, D; Stambuk, K; Zdravko, B; Tomulic, V; Krstulovic, SM; Starcevic, B; Spinar, J; Horak, D; Stasek, J; Alan, D; Machova, V; Linhart, A; Novotny, V; Kaucak, V; Rokyta, R; Naplava, R; Coufal, Z; Adamkova, V; Podpera, I; Zizka, J; Motovska, Z; Marusincova, I; Svab, P; Heinc, P; Kuchar, J; Povolny, P; Matuska, J; Raungaard, B; Clemmensen, P; Bang, LE; May, O; Bottcher, M; Hove, JD; Frost, L; Gislason, G; Larsen, J; Johansen, PB; Hald, F; Jeppesen, J; Nielsen, T; Kristensen, KS; Walichiewicz, PM; Lomholdt, JD; Klausen, IC; Nielsen, PK; Davidsen, F; Videbaek, L; Soots, M; Vahula, V; Hedman, A; Soopold, U; Martsin, K; Kristjan, A; Taskinen, M-R; Porthan, K; Airaksinen, JK; Juonala, M; Kiviniemi, T; Vikman, S; Posio, P; Taurio, J; Huikuri, H; Kaikkonen, K; Coste, P; Ferrari, E; Morel, O; Montalescot, G; Barone-Rochette, G; Mansourati, J; Cottin, Y; Leclercq, F; Belhassane, A; Delarche, N; Boccara, F; Paganelli, F; Clerc, J; Schiele, F; Aboyans, V; Probst, V; Berland, J; Lefevre, T; Citron, B; Khintibidze, I; Shaburishvili, T; Pagava, Z; Ghlonti, R; Lominadze, Z; Khabeishvili, G; Hemetsberger, R; Rauch-Kroehnert, U; Stratmann, M; Appel, K-F; Schmidt, E; Omran, H; Stellbrink, C; Dorsel, T; Lianopoulos, E; Marx, R; Zirlik, A; Schellenberg, D; Heitzer, T; Laufs, U; Gielen, S; Winkelmann, B; Behrens, S; Sydow, K; Simonis, G; Muenzel, T; Werner, N; Leggewie, S; Boecker, D; Braun-Dullaeus, R; Toursarkissian, N; Jeserich, M; Weissbrodt, M; Schaeufele, T; Weil, J; Voeller, H; Waltenberger, J; Natour, M; Schmitt, S; Steiner, S; Heidenreich, L; Gremmler, U; Killat, H; Rieker, W; Patsilinakos, S; Kartalis, A; Manolis, A; Sionis, D; Skoumas, I; Athyros, V; Vardas, P; Parthenakis, F; Alexopoulos, D; Hahalis, G; Lekakis, J; Hatzitolios, A; Ovando, SRF; Benecke, JLA; De Leon, ERR; Yan, BPY; Siu, DCW; Turi, T; Merkely, B; Ungi, I; Lupkovics, G; Nagy, L; Katona, A; Edes, I; Muller, G; Horvath, I; Kapin, T; Falukozy, J; Kumbla, M; Sandhu, M; Annam, S; Proddutur, NR; Premchand, RK; Mahajan, A; Abhyanakar, AD; Kerkar, P; Govinda, RA; Oomman, A; Sinha, D; Patil, SN; Kahali, D; Sawhney, J; Joshi, AB; Chaudhary, S; Harkut, P; Guha, S; Porwal, S; Jujjuru, S; Pothineni, RB; Monteiro, MR; Khan, A; Iyengar, SS; Grewal, JS; Chopda, M; Fulwani, MC; Patange, A; Chopra, VK; Goyal, NK; Shinde, R; Manakshe, GV; Patki, N; Sethi, S; Munusamy, V; Karna, S; Adhyapak, S; Pandurangi, U; Mathur, R; Kalashetti, S; Bhagwat, A; Raghuraman, B; Yerra, SK; Bhansali, P; Borse, R; Das, S; Abdullakutty, J; Saathe, S; Palimkar, P; Abdullkutty, J; Sathe, S; Atar, S; Shechter, M; Mosseri, M; Arbel, Y; Lotan, C; Rosenschein, U; Katz, A; Henkin, Y; Francis, A; Klutstein, M; Nikolsky, E; Turgeman, Y; Halabi, M; Kornowski, R; Jonas, M; Amir, O; Rozenman, Y; Fuchs, S; Hussein, O; Gavish, D; Vered, Z; Caraco, Y; Elias, M; Tov, N; Lishner, M; Elias, N; Piovaccari, G; De Pellegrin, A; Guardigli, G; Licciardello, G; Auguadro, C; Cuccia, C; Salvioni, A; Musumeci, G; Calabro, P; Novo, S; Faggiano, P; De Cesare, NB; Berti, S; Cavallini, C; Puccioni, E; Galvani, M; Tespili, M; Piatti, P; Palvarini, M; De Luca, G; Violini, R; De Leo, A; Filardi, PP; Ferratini, M; Ricca, V; Dai, K; Kamiya, H; Ando, K; Takeda, Y; Morino, Y; Hata, Y; Kimura, K; Kishi, K; Michishita, I; Uehara, H; Higashikata, T; Hirayama, A; Hirooka, K; Sakagami, S; Taguchi, S; Koike, A; Fujinaga, H; Koba, S; Kozuma, K; Kawasaki, T; Ono, Y; Shimizu, M; Katsuda, Y; Wada, A; Shinke, T; Ako, J; Fujii, K; Takahashi, T; Sakamoto, T; Furukawa, Y; Sugino, H; Mano, T; Utsu, N; Ito, K; Haraguchi, T; Ueda, Y; Nishibe, A; Fujimoto, K; Masutani, M; Yoon, JH; Park, HS; Chae, I-H; Kim, MH; Jeong, MH; Rha, S; Kim, C; Kim, H-S; Hong, T; Tahk, S-J; Kim, Y; Busmane, A; Pontaga, N; Strelnieks, A; Mintale, I; Sime, I; Petrulioniene, Z; Kavaliauskiene, R; Jurgaitiene, R; Sakalyte, G; Slapikas, R; Norkiene, S; Misonis, N; Kibarskis, A; Kubilius, R; Bojovski, S; Lozance, N; Kjovkaroski, A; Doncovska, S; Ong, TK; Kasim, S; Maskon, O; Kandasamy, B; Liew, HB; Mohamed, WMIW; Garcia Castillo, A; Carrillo Calvillo, J; Fajardo Campos, P; Nunez Fragoso, JC; Bayram Llamas, EA; Alcocer Gamba, MA; Carranza Madrigal, J; Gonzalez Salas, LG; Lopez Rosas, E; Gonzalez Diaz, B; Salcido Vazquez, E; Nacoud Ackar, A; Llamas Esperon, GA; Martinez Sanchez, CR; Guerrero De Leon, M; Suarez Otero, R; Fanghanel Salmon, G; Perez Rios, JA; Garza Ruiz, JA; Breedveld, RW; Hoogslag, PAM; Suryapranata, H; Oomen, A; Wiersma, JJ; Van Der Wal, RMA; Van Huysduynen-Monraats, PSH; Karalis, I; Verdel, GJE; Brueren, BRG; Troquay, RP; Viergever, EP; Al-Windy, NYY; Bartels, GL; Cornel, JH; Hermans, WRM; Herrman, JPR; Bos, RJ; Groutars, RGEJ; Van Der Zwaan, CC; Kaplan, R; Ronner, E; Groenemeijer, BE; Bronzwaer, PNA; Liem, AAH; Rensing, BJWM; Bokern, MJJA; Nijmeijer, R; Hersbach, FMRJ; Willems, FF; Gosselink, ATM; Elliott, J; Wilkins, G; Fisher, R; Scott, D; Hart, H; Stewart, R; Harding, S; Ternouth, I; Fisher, N; Aitken, D; Anscombe, R; Davidson, L; Tomala, T; Nygard, O; Sparby, JA; Andersen, K; Gullestad, L; Jortveit, J; Munk, PS; Singsaas, EG; Hurtig, U; Calderon Ticona, JR; Durand Velasquez, JR; Negron Miguel, SA; Sanabria Perez, ES; Carrion Chambilla, JM; Chavez Ayala, CA; Castillo Leon, RP; Vargas Gonzales, RJ; Hernandez Zuniga, JD; Camacho Cosavalente, LA; Bravo Mannucci, JE; Heredia Landeo, J; Llerena Navarro, NC; Roldan Concha, YM; Rodriguez Chavez, V-CE; Anchante Hernandez, HA; Zea Nunez, CA; Mogrovejo Ramos, W; Ferrolino, A; Sy, RAG; Tirador, L; Matiga, G; Coching, RM; Bernan, A; Rogelio, G; Morales, DD; Tan, E; Sulit, DJ; Wlodarczak, A; Jaworska, K; Skonieczny, G; Pawlowicz, L; Wojewod, P; Busz-Papiez, B; Bednarski, J; Goch, A; Staneta, P; Dulak, E; Saminsk, K; Krasowski, W; Sudnik, W; Zurakowski, A; Skorski, M; Lysek, R; Miklaszewicz, B; Kubica, J; Lipko, JA; Kostarska-Srokosz, E; Piepiorka, M; Drzewiecka, A; Sciborski, R; Stasiewski, A; Blicharski, T; Bystryk, L; Szpajer, M; Korol, M; Czerski, T; Mirek-Bryniarska, E; Gniot, J; Lubinski, A; Gorny, J; Franek, E; Raczak, G; Szwed, H; Monteiro, P; Bastos, JM; Pereira, HH; Martins, D; Seixo, F; Mendonca, C; Botelho, A; Minescu, B; Istratoaie, O; Tesloianu, DN; Cristian, G; Podoleanu, CGC; Constantinescu, MCA; Bengus, CM; Militaru, C; Rosu, D; Parepa, IR; Matei, AV; Alexandru, TM; Coman, I; Cioranu, RS; Dimulescu, D; Shvarts, Y; Orlikova, O; Kobalava, Z; Barbarash, OL; Markov, V; Lyamina, N; Gordienko, A; Zrazhevsky, K; Vishnevsky, AY; Gurevich, V; Stryuk, R; Lomakin, NV; Bokarev, I; Shalaev, S; Khaisheva, L; Chizhov, P; Viktorova, I; Osokina, N; Akatova, E; Chumakova, G; Libov, I; Voevoda, MI; Tretyakova, TV; Baranov, E; Shustov, S; Yakushin, S; Gordeev, I; Khasanov, N; Reshetko, O; Sotnikova, T; Molchanova, O; Nikolaev, K; Gapon, L; Baranova, E; Shogenov, Z; Kosmachova, E; Povzun, A; Egorova, L; Tyrenko, VV; Ivanov, IG; Kanorsky, S; Simic, D; Ivanovic, N; Davidovic, G; Tasic, N; Asanin, MR; Stojic, S; Apostolovic, SR; Ilic, S; Putnikovic, B; Stankovic, A; Arandjelovic, A; Radovanovic, S; Balinovac, J; Dincic, DV; Seferovic, P; Dodic, S; Dimkovic, S; Poh, K-K; Ong, HY; Micko, K; Nociar, J; Pella, D; Fulop, P; Hranai, M; Palka, J; Mazur, J; Majercak, I; Dzupina, A; Fazekas, F; Gonsorcik, J; Bugan, V; Selecky, J; Kamensky, G; Strbova, J; Smik, R; Dukat, A; Olexa, P; Zuran, I; Poklukar, J; Suligoj, NC; Cevc, M; Cyster, HP; Ranjith, N; Corbett, C; Bayat, J; Makotoko, EM; Kapp, IE; Basson, MMDV; Lottering, H; Van Zyl, LJ; Sebastian, PJ; Pillay, T; Saaiman, JA; Commerford, PJ; Cassimjee, S; Ebrahim, IO; Sarvan, M; Mynhardt, JH; Reuter, H; Moodley, R; Vida, M; Cequier Fillat, AR; Peris, VB; Jimenez, FF; Marin, F; Cruz Fernandez, JM; Gil-Extremera, B; Diz, FW; Garcia-Dorado, D; Iniguez, A; Tunon Fernandez, J; Gonzalez-Juanatey, JR; Fernandez Portales, J; Civeira Murillo, F; Matas Pericas, L; Luis Zamorano, J; De Mora Martin, M; Bruguera Cortada, J; Alonso Martin, JJ; De Berrazueta Fernandez, JR; Diaz Fernandez, JF; Garcia Lledo, JA; Cosin Sales, J; Botas Rodriguez, J; Gusi Tragant, G; Benedicto, A; Gonzalez-Juanatey, C; Camprubi Potau, M; Plaza Perez, I; Moris De La Tassa, C; Loma-Osorio Rincon, P; Balaguer Recena, J; Escudier, JM; Coca Payeras, A; Alonso Orcajo, N; Valdivielso, P; Constantine, G; Haniffa, R; Tissera, N; Amarasekera, S; Fernando, N; Jayawardena, J; Santharaj, W; Ekanayaka, R; Mendis, S; Senaratne, V; Mayurathan, G; Sirisena, T; Rajapaksha, A; Herath, JI; Amarasena, N; Berglund, S; Rasmanis, G; Witt, N; Mourtzinis, G; Nicol, P; Hansen, O; Romeo, S; Jensen, SA; Torstensson, I; Ahremark, U; Sundelin, T; Moccetti, T; Mach, F; Binder, R; Tsai, W-C; Ueng, K-C; Lai, W-T; Liu, M-E; Hwang, J-J; Yin, W-H; Hsieh, I-C; Lin, WH; Kuo, J-Y; Huang, T-Y; Fang, C-Y; Kaewsuwanna, P; Soonfuang, W; Jintapakorn, W; Sukonthasarn, A; Wongpraparut, N; Sastravaha, K; Sansanayudh, N; Kehasukcharoen, W; Piyayotai, D; Chotnoparatpat, P; Camsari, A; Kultursay, H; Mutlu, B; Ersanli, M; Demirtas, M; Kirma, C; Ural, E; Koldas, L; Karpenko, O; Prokhorov, A; Vakaluyk, I; Myshanych, H; Reshotko, D; Batushkin, V; Rudenko, L; Kovalskyi, I; Kushnir, M; Tseluyko, V; Mostovoy, Y; Stanislavchuk, M; Kyiak, Y; Karpenko, Y; Malynovsky, Y; Klantsa, A; Kutniy, O; Amosova, E; Tashchuk, V; Leshchuk, O; Rishko, M; Kopytsya, M; Yagensky, A; Vatutin, M; Bagriy, A; Barna, OM; Ushakov, O; Dzyak, G; Goloborodko, B; Rudenko, A; Zheleznyy, V; Trevelyan, J; Zaman, A; Lee, K; Moriarty, A; Aggarwal, RK; Clifford, P; Wong, Y-K; Iqbal, SMR; Subkovas, E; Braganza, D; Sarkar, D; Storey, R; Griffiths, H; Mcclure, S; Muthusamy, R; Kurian, J; Levy, T; Barr, C; Kadr, H; Gerber, R; Simaitis, A; Soran, H; Mathur, A; Brodison, A; Oliver, R; Mudawi, T; Reynolds, T; Sharman, D; Butler, R; Wilkinson, P; Lip, GYH; Halcox, J; Vardi, G; Baldari, D; Brabham, D; Treasure, C; Dahl, C; Palmer, B; Wiseman, A; Puri, S; Mohart, AE; Ince, C; Flores, E; Wright, S; Cheng, S-C; Rosenberg, M; Rogers, W; Kosinski, E; Forgosh, L; Waltman, J; Khan, M; Shoukfeh, M; Dagher, G; Lieber, I; Kumar, P; East, C; Krichmar, P; White, L; Knickelbine, T; Haldis, T; Gillespie, E; Suh, D; Arif, I; Akhter, F; Carlson, E; D'Urso, M; El-Ahdab, F; Nelson, W; Harris, B; Cohen, S; Carter, L; Sabatino, K; Haddad, T; Malik, A; Rao, S; Mulkay, A; Jovin, I; Klancke, K; Malhotra, V; Devarapalli, SK; Koren, M; Chandna, H; Dodds, G; Janik, M; Moran, J; Sumner, A; Kobayashi, J; Davis, W; Yazdani, S; Pasquini, J; Thakkar, M; Vedere, A; Leimbach, W; Rider, J; Singh, N; Shah, AV; Janosik, D; Pepine, C; Berman, B; Gelormini, J; Daniels, C; Keating, F; Kondo, NI; Shetty, S; Waider, W; Takata, T; Abu-Fadel, M; Shah, V; Aggarwal, R; Izzo, M; Kumar, A; Hattler, B; Link, C; Bortnick, A; Kinzfogl, G; Ghitis, A; Larry, J; Teufel, E; Kuhlman, P; Mclaurin, B; Zhang, W; Thew, S; Abbas, J; White, M; Ranadive, N; Gring, C; Henderson, D; Schuchard, T; Farhat, N; Kline, G; Mahal, S; Whitaker, J; Speirs, S; Andersen, R; Daboul, N; Horwitz, P; Ponce, G; Jafar, Z; Mcgarvey, J; Panchal, V; Voyce, S; Blok, T; Sheldon, W; Azizad, MM; Schmalfuss, C; Picone, M; Herzog, W; Lindsey, J; Nowins, R; Lepor, N; El Shahawy, M; Weintraub, H; Irimpen, A; May, W; Galski, T; Chu, A; Mody, F; Hodes, Z; Rose, G; Fairlamb, J; Lambert, C; Raisinghani, A; Abbate, A; King, M; Carey, C; Gerber, J; Younis, L; Park, HT; Vidovich, M; Knutson, T; Friedman, D; Chaleff, F; Loussararian, A; Rozeman, P; Kimmelstiel, C; Silver, K; Foster, M; Tonnessen, G; Amlani, M; Wali, A; Malozzi, C; Wattanakit, K; O'Donnell, PJ; Singal, D; Jaffrani, N; Banuru, S; Fisher, D; Xenakis, M; Perlmutter, N; Bhagwat, R; Strader, J; Akyea-Djamson, A; Labroo, A; Marais, HJ; Claxton, E; Berk, M; Rossi, P; Joshi, P; Khaira, AS; Kumkumian, G; Lupovitch, S; Purow, J; Welka, S; Hoffman, D; Fischer, S; Soroka, E; Eagerton, D; Pancholy, S; Ray, M; Farrar, M; Pollock, S; French, WJ; Diamantis, S; Gimple, L; Neustel, M; Schwartz, S; Pereira, E; Spriggs, D; Strain, J; Vo, A; Chane, M; Hall, J; Vijay, N; Lotun, K; Lester, FM; Nahhas, A; Pope, T; Nager, P; Vohra, R; Bashir, R; Ahmed, H; Berlowitz, M; Fishberg, R; Barrucco, R; Yang, E; Radin, M; Sporn, D; Eisenberg, S; Landzberg, J; Mcgough, M; Turk, S; Schwartz, M; Sundram, PS; Jain, D; Zainea, M; Bayron, C; Karlsberg, R; Lui, H; Keen, W; Westerhausen, D; Khurana, S; Agarwal, H; Birchem, J; Penny, W; Chang, M; Murphy, S; Schifferdecker, B; Gilbert, JM; Chalavarya, G; Eaton, C; Schmedtje, JF; Christenson, S; Denham, D; Macdonell, A; Gibson, P; Rahman, A; Al Joundi, T; Conrad, G; Kotha, P; Love, M; Giesler, G; Rubenstein, H; Akright, L; Krawczyk, J; Wells, T; Welker, J; Foster, R; Gilmore, R; Anderson, J; Jacoby, D; Gardner, G; Dandillaya, R; Vora, K; Kostis, J; Hunter, J; Laxson, D; Ball, E; Camp, A; Lopes, R; Egydio, F; Kawakami, A; Oliveira, J; Wozniak, J; Matthews, A; Ratky, C; Valiris, J; Berdan, L; Hepditch, A; Quintero, K; Rorick, T; Westbrook, M; Pascual, A; Rovito, C; Bezault, M; Drouet, E; Simon, T; Alsweiler, C; Luyten, A; Aylward, P; Butters, J; Griffith, L; Shaw, M; Grunberg, L; Islam, S; Bougon, N; Faustino, D; Fontecave, S; Murphy, J; Verrier, M; Agnetti, V; Andersen, D; Badreddine, E; Bekkouche, M; Bouancheau, C; Brigui, I; Brocklehurst, M; Cianciarulo, J; Devaul, D; Domokos, S; Gache, C; Gobillot, C; Guillou, S; Healy, J; Heath, M; Jaiwal, G; Javierre, C; Labeirie, J; Monier, M; Morales, U; Mrabti, A; Mthombeni, B; Okan, B; Smith, L; Sheller, J; Sopena, S; Pellan, V; Benbernou, F; Bengrait, N; Lamoureux, M; Kralova, K; Scemama, M; Bejuit, R; Coulange, A; Berthou, C; Repincay, J; Lorenzato, C; Etienne, A; Gouet, V; Loizeau, V; Normand, M; Ourliac, A; Rondel, C; Adamo, A; Beltran, P; Barraud, P; Dubois-Gache, H; Halle, B; Metwally, L; Mourgues, M; Sotty, M; Vincendet, M; Cotruta, R; Zhu, C; Fournie-Lloret, D; Morrello, C; Perthuis, A; Picault, P; Zobouyan, I

Circulation
CIRCULATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Steg, P G, Szarek, M, Bhatt, D L, Bittner, V A, Bregeault, M-F, Dalby, A J, Diaz, R, Edelberg, J M, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Lecorps, G, Mahaffey, K W, Moryusef, A, Ostadal, P, Parkhomenko, A, Pordy, R, Roe, M T, Tricoci, P, Vogel, R, White, H D, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Clemmensen, P, Gislason, G, Davidsen, F & Videbaek, L 2019, ' Effect of Alirocumab on Mortality After Acute Coronary Syndromes : An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial ', Circulation, vol. 140, no. 2, pp. 103-112 . https://doi.org/10.1161/CIRCULATIONAHA.118.038840
Circulation : an official journal of the American Heart Association 140(2), 103-112 (2019). doi:10.1161/CIRCULATIONAHA.118.038840

Hamilton, Garry W. ; Koshy, Anoop N. ; Dinh, Diem ; Brennan, Angela ; Yeoh, Julian ; Yudi, Matias B. ; Horrigan, Mark ; Reid, Christopher M. ; Stub, Dion ; Chan, William ; Oqueli, Ernesto ; Freeman, Melanie ; Hiew, Chin ; Ajani, Andrew ; Farouque, Omar ; Clark, David J.

In Cardiovascular Revascularization Medicine August 2024

Hiscock, Martin ; Oqueli, Ernesto; Dick, Ron

In Heart, Lung and Circulation 2007 16 Supplement 3:S51-S55

Steg PG; Université Paris-Cité, INSERM-U1148, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, French Alliance for Cardiovascular Trials (P.G.S.).; Szarek M; University of Colorado School of Medicine, Aurora (M.S.).; State University of New York, Downstate School of Public Health, Brooklyn (M.S.).; Jukema JW; Leiden University Medical Center, the Netherlands (J.W.J.).; Bhatt DL; Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, NY (D.L.B.).; Bittner VA; Division of Cardiovascular Disease, University of Alabama at Birmingham (V.A.B.).; Diaz R; Estudios Cardiológicos Latino América, Instituto Cardiovascular de Rosario, Argentina (R.D.).; Fazio S; Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.F.).; Garon G; Sanofi, Montreal, Canada (G.G.).; Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, AB (S.G.G.).; St. Michael's Hospital, Unity Health Toronto, and Peter Munk Cardiac Centre, University Health Network, University of Toronto, ON, Canada (S.G.G.).; Harrington RA; Cornell University, New York, NY (R.A.H.).; White HD; Green Lane Cardiovascular Research Unit, Te Whatu Ora-Health New Zealand, Te Toka Tumai, and University of Auckland (H.D.W.).; Zeiher AM; Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Schwartz GG; Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.).

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: In Process; MEDLINE

Schwartz GG; Division of Cardiology, University of Colorado School of Medicine, Aurora, CO gregory.schwartz@cuanschutz.edu.; Szarek M; Division of Cardiology, University of Colorado School of Medicine, Aurora, CO.; CPC Clinical Research, Aurora, CO.; Downstate School of Public Health, State University of New York, Brooklyn, NY.; Bittner VA; University of Alabama at Birmingham, Birmingham, AL.; Bhatt DL; Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Diaz R; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina.; Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada.; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.; Jukema JW; Leiden University Medical Center, Leiden, the Netherlands.; Loy M; Sanofi, Bridgewater, NJ.; Manvelian G; Regeneron Pharmaceuticals, Tarrytown, NY.; Pordy R; Regeneron Pharmaceuticals, Tarrytown, NY.; White HD; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand.; Steg PG

Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE

Batra G; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; Ghukasyan Lakic T; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.; Lindbäck J; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.; Held C; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; White HD; Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand.; Stewart RAH; Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand.; Koenig W; Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.; Deutsches Herzzentrum München, Technische Universität München, DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.; Cannon CP; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.; Budaj A; Department of Cardiology, Centre of Postgraduate Medical Education, Grochowski Hospital, Warsaw, Poland.; Hagström E; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.; Siegbahn A; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.; Wallentin L; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101676033 Publication Model: Print Cited Medium: Internet ISSN: 2380-6591 (Electronic) NLM ISO Abbreviation: JAMA Cardiol Subsets: MEDLINE

Hagström E; Uppsala University, Department of Medical Sciences, and Uppsala Clinical Research Center, Sweden (E.H.).; Steg PG; Department of Cardiology, Université de Paris, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, FACT (French Alliance for Cardiovascular Trials), and INSERM U1148, France (P.G.S.).; Imperial College, Royal Brompton Hospital, London, UK (P.G.S.).; Szarek M; CPC Clinical Research (M. Szarek), University of Colorado School of Medicine, Aurora.; Division of Cardiology (M. Szarek, G.G.S.), University of Colorado School of Medicine, Aurora.; State University of New York, Downstate Health Sciences University, Brooklyn (M. Szarek).; Bhatt DL; Department of Medicine, Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA (D.L.B.).; Bittner VA; Division of Cardiovascular Disease, University of Alabama at Birmingham (V.A.B.).; Danchin N; Department of Cardiology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France (N.D.).; Université Paris Descartes, France (N.D.).; Diaz R; Estudios Cardiológicos Latino América, Instituto Cardiovascular de Rosario, Argentina (R.D.).; Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (S.G.G.).; St. Michael's Hospital, University of Toronto, Ontario, Canada (S.G.G.).; Harrington RA; Stanford Center for Clinical Research, Department of Medicine, Stanford University, CA (R.A.H.).; Jukema JW; Department of Cardiology, Leiden University Medical Center, the Netherlands (J.W.J.).; Netherlands Heart Institute, Utrecht (J.W.J.).; Liberopoulos E; School of Medicine, National and Kapodistrian University of Athens, Greece (E.L.).; Marx N; University Hospital, RWTH Aachen University, Germany (N.M.).; McGinniss J; Regeneron Pharmaceuticals Inc, Tarrytown, NY (J.M., G.M., R.P.).; Manvelian G; Regeneron Pharmaceuticals Inc, Tarrytown, NY (J.M., G.M., R.P.).; Pordy R; Regeneron Pharmaceuticals Inc, Tarrytown, NY (J.M., G.M., R.P.).; Scemama M; Sanofi, Paris, France (M. Scemama).; White HD; Green Lane Cardiovascular Services, Auckland City Hospital and Auckland University, New Zealand (H.D.W.).; Zeiher AM; Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Schwartz GG; Division of Cardiology (M. Szarek, G.G.S.), University of Colorado School of Medicine, Aurora.

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE

Schwartz GG; Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA. Electronic address: gregory.schwartz@cuanschutz.edu.; Szarek M; State University of New York, Downstate School of Public Health, Brooklyn, New York, USA; CPC Clinical Research and Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado, USA.; Bittner VA; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Diaz R; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina.; Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada; St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.; Jukema JW; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands; Netherlands Heart Institute, Utrecht, the Netherlands.; Landmesser U; Department of Cardiology, Charité Universitätsmedizin Berlin, Berlin, Germany.; López-Jaramillo P; Masira Research Institute, Medical School (UDES), Bucaramanga, Colombia.; Manvelian G; Regeneron Pharmaceuticals, Tarrytown, New York, USA.; Pordy R; Regeneron Pharmaceuticals, Tarrytown, New York, USA.; Scemama M; Sanofi, Paris, France.; Sinnaeve PR; Department of Cardiovascular Medicine, University Hospitals Leuven, Leuven, Belgium.; White HD; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand.; Gabriel Steg P; Université de Paris, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, French Alliance for Cardiovascular Trials, and INSERM U1148, Paris, France; Imperial College, Royal Brompton Hospital, London, United Kingdom. Electronic address: https://twitter.com/gabrielsteg.

Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE

Ray KK; Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, Imperial College London, London, UK. Electronic address: k.ray@imperial.ac.uk.; Colhoun HM; University of Edinburgh, Edinburgh, Scotland, UK.; Szarek M; State University of New York, Downstate School of Public Health, Brooklyn, NY, USA.; Baccara-Dinet M; Sanofi, Montpellier, France.; Bhatt DL; Heart & Vascular Center, Brigham and Women's Hospital Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Bittner VA; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA.; Budaj AJ; Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland.; Diaz R; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina.; Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada; St Michael's Hospital, University of Toronto, Toronto, ON, Canada.; Hanotin C; Sanofi, Paris, France.; Harrington RA; Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA, USA.; Jukema JW; Department of Cardiology, Leiden University Medical Center, Leiden, Netherlands.; Loizeau V; Sanofi, Paris, France.; Lopes RD; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA; Duke University, Durham, NC, USA.; Moryusef A; Sanofi, Bridgewater, NJ, USA.; Murin J; 1st Internal Department, Comenius University, University Hospital, Bratislava, Slovakia.; Pordy R; Regeneron Pharmaceuticals, Tarrytown, NY, USA.; Ristic AD; Department of Cardiology, Clinical Center of Serbia, Belgrade University School of Medicine, Belgrade, Serbia.; Roe MT; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.; Tuñón J; Fundación Jiménez Díaz, Madrid, Spain.; White HD; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand.; Zeiher AM; Department of Medicine III, Goethe University, Frankfurt, Germany.; Schwartz GG; Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA.; Steg PG; National Heart and Lung Institute, Royal Brompton Hospital, Imperial College London, London, UK; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Université de Paris, FACT (French Alliance for Cardiovascular Trials), INSERM U1148, Paris, France.

Publisher: The Lancet, Diabetes & Endocrinology Country of Publication: England NLM ID: 101618821 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-8595 (Electronic) Linking ISSN: 22138587 NLM ISO Abbreviation: Lancet Diabetes Endocrinol Subsets: MEDLINE

Schwartz GG; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Steg PG; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Szarek M; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Bhatt DL; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Bittner VA; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Diaz R; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Edelberg JM; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Goodman SG; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Hanotin C; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Harrington RA; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Jukema JW; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Lecorps G; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Mahaffey KW; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Moryusef A; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Pordy R; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Quintero K; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Roe MT; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Sasiela WJ; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Tamby JF; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Tricoci P; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; White HD; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).; Zeiher AM; From the Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.); Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Paris Diderot University, Sorbonne Paris Cité, FACT (French Alliance for Cardiovascular Trials), and INSERM Unité 1148 (P.G.S.), and Sanofi (C.H., G.L.) - all in Paris; the National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.); the State University of New York Downstate School of Public Health, Brooklyn (M.S.), and Regeneron Pharmaceuticals, Tarrytown (R.P., W.J.S.) - both in New York; Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.); the Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham (V.A.B.); Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina (R.D.); Sanofi, Bridgewater, NJ (J.M.E., A.M., J.-F.T.); the Canadian VIGOUR Centre, University of Alberta, Edmonton, and St. Michael's Hospital, University of Toronto, Toronto - both in Canada (S.G.G.); Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA (R.A.H., K.W.M.); the Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands (J.W.J.); Duke Clinical Research Institute, Duke University Medical Center (K.Q., M.T.R., P.T.), and the Division of Cardiology, Department of Medicine, Duke University School of Medicine (M.T.R.), Durham, NC; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand (H.D.W.); and the Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Bohula EA; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Wiviott SD; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; McGuire DK; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Inzucchi SE; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Kuder J; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Im K; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Fanola CL; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Qamar A; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Brown C; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Budaj A; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Garcia-Castillo A; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Gupta M; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Leiter LA; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Weissman NJ; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; White HD; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Patel T; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Francis B; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Miao W; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Perdomo C; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Dhadda S; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Bonaca MP; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Ruff CT; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Keech AC; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Smith SR; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Sabatine MS; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Scirica BM; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

White HD; Held C; Stewart R; Tarka E; Brown R; Davies RY; Budaj A; Harrington RA; Steg PG; Ardissino D; Armstrong PW; Avezum A; Aylward PE; Bryce A; Chen H; Chen MF; Corbalan R; Dalby AJ; Danchin N; De Winter RJ; Denchev S; Diaz R; Elisaf M; Flather MD; Goudev AR; Granger CB; Grinfeld L; Hochman JS; Husted S; Kim HS; Koenig W; Linhart A; Lonn E; López-Sendón J; Manolis AJ; Mohler ER 3rd; Nicolau JC; Pais P; Parkhomenko A; Pedersen TR; Pella D; Ramos-Corrales MA; Ruda M; Sereg M; Siddique S; Sinnaeve P; Smith P; Sritara P; Swart HP; Sy RG; Teramoto T; Tse HF; Watson D; Weaver WD; Weiss R; Viigimaa M; Vinereanu D; Zhu J; Cannon CP; Wallentin L

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE